Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Toscano, Elisa
Martínez, Kenia
Fraguas, David
Janssen, Joost
Pina-Camacho, Laura
Arias, Bárbara
Vieta, Eduard
Mezquida, Gisela
Amoretti, Silvia
Bernardo, Miguel
Castro-Fornieles, Josefina
Cuesta-Zorita, Manuel Jesús
Lobo, Antonio
González-Pinto, Ana
Collado, Iluminada Corripio
Mané, Anna
Arango, Celso
Parellada, Mara
-
Funding
Funding for this research was provided by:
Eusko Jaurlaritza
Ministerio de Economía y Competitividad
Eli Lilly and Company
Instituto de Salud Carlos III
Stanley Medical Research Institute
Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
H2020 (115916)
Innovative Medicines Initiative
European Commission
Generalitat de Catalunya (2017 SGR 1365, SLT006/17/00357)
Centro de Investigación Biomédica en Red de Salud Mental (AGES-CM-2, S2010/BMD-2422 AGES)
FP7 Health
Ministerio de Ciencia, Innovación y Universidades
European Regional Development Fund
Cilag
Ministerio de Ciencia e Innovación
Fundación Mutua Madrileña
Seventh Framework Programme (FP7-HEALTH- F4-2010-241959, FP7-HEALTH-2009-2.2.1-2-241909, FP7-HEALTH-2013-2.2.1-2-603196)
Fundación Alicia Koplowitz
Comunidad de Madrid Consejeria de Sanidad
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis
Journal Title: Revista de Psiquiatría y Salud Mental
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsm.2021.11.002
Content Type: article
Copyright: © 2021 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.
